Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the independent Data ...

SAN FRANCISCO, April 16, 2026 /PRNewswire/ -- MasterClass, the personalized learning platform unlocking human potential with the world's best, today announced the launch of Revolutionize Your ...

The Master of Information and Data Science (MIDS) is an online degree preparing data science professionals to solve ...

The initiative partners with the Stanley's ArtInfuse Teaching Program to help students use art to better understand economics ...

LLMs are quietly reshaping data journalism workflows at The Hindu, helping reporters process vast document sets, write ...

Cetera Financial and Ameriprise are the latest financial services firms to face allegations of data breaches detailed in class action lawsuits brought by customers, calling them to task for allegedly ...

Discover how Tableau Data Visualization, BI dashboards, and Tableau Prep work together as a powerful data visualization tool for interactive charts, cleaner data, and clearer data storytelling.

Hightower is the latest firm facing a class-action lawsuit in the wake of an alleged cybercriminal data breach of client information. Elliott Adams, who claims he is a former employee of the firm, ...

Salary is one major factor long linked to teacher morale. In an effort to look more holistically at the forces influencing educators’ satisfaction on the job, the EdWeek Research Center asked about ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A major health care company has agreed to pay $14 million over claims that it suffered a data breach that exposed ...

This article is not about ethics, privacy, security, ownership, or corporate governance — I am going to circumvent all of this here by using some made-up data relating to supermarket sales: Here, I ...

Alume Biosciences delivers positive topline results for three pivotal trials of Bevonescein, advancing toward NDA submission with US FDA in 2H 2026 Even with meticulous technique, surgeons are limited ...